ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 135 filers reported holding ANTARES PHARMA INC in Q3 2019. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $525,000 | +6.1% | 120,200 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $495,000 | +3.1% | 120,200 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $480,000 | +47.7% | 120,200 | 0.0% | 0.01% | +50.0% |
| Q3 2020 | $325,000 | -81.4% | 120,200 | -81.1% | 0.00% | -83.3% |
| Q2 2020 | $1,745,000 | +16.6% | 634,400 | +0.1% | 0.02% | 0.0% |
| Q1 2020 | $1,496,000 | -44.4% | 633,800 | +0.3% | 0.02% | -11.1% |
| Q4 2019 | $2,692,000 | +203.5% | 631,700 | +138.4% | 0.03% | +170.0% |
| Q3 2019 | $887,000 | +1.7% | 265,000 | 0.0% | 0.01% | +11.1% |
| Q2 2019 | $872,000 | +8.6% | 265,000 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $803,000 | – | 265,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |